Thalidomide for Dermatologic Conditions | Therapeutic Cheat Sheet
Thalidomide was introduced in the 1950s as a “safe” sleeping medication; however, it quickly became vilified and was removed from the market for its severe teratogenic effects, most commonly phecomelia, or loss of arms and legs. Despite these devastating birth defects, thalidomide has a variety of indications for dermatologic conditions, with manageable side effects when used appropriately. We …
Thalidomide was introduced in the 1950s as a “safe” sleeping medication; however, it quickly became vilified and was removed from the market for its severe teratogenic effects, most commonly phecomelia, or loss of arms and legs. Despite these devastating birth defects, thalidomide has a variety of indications for dermatologic conditions, with manageable side effects when used appropriately. We … Continue reading "Thalidomide for Dermatologic Conditions | Therapeutic Cheat Sheet"
With a special focus on lasers, light sources, and devices, the November issue of the Journal of Drugs in Dermatology features an outstanding line up of editorials and original articles on topics ranging from deoxycholic acid (ATX-101) for fat reduction, treating molluscum contagiosum, skincare for neonates and infants, laser in the treatment of granulomas on the nose, and everything in between … 
During the 2021 Skin of Color Update Virtual Conference, Dr. Hassan Galadari provided a highly anticipated lecture in which he discussed prevention and management of complications with dermal filler injections.
[caption id="attachment_14289" align="alignleft" width="1024"] Table 1[/caption]
The different types of dermal filers, shown above in Table 1, have been associated with a variety of c … 
Rosacea is defined by facial erythema and telangiectasias, two features that are more difficult to appreciate in patients with skin of color. To refine our ability to diagnose rosacea in all skin types, on day two of the 2021 Skin of Color Update virtual conference, we had an informative, evidence-based lecture, “Recognizing, Diagnosing, and Treating Rosacea in Patients with Skin of Color,” by … 
Hyperhidrosis affects up to 4.8% of people in the United States, causing significant impacts in patient quality of life.1 Often times, the etiology of symptoms cannot be identified, resulting in a subset of disease termed “primary hyperhidrosis.” Symptoms may be focal or generalized. Because there is a scarcity of FDA-approved treatments for primary hyperhidrosis, treatment often requires a mu … 